GLEN BURNIE, Md.--(BUSINESS WIRE)--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces the launch of AccuSom Deliver™, a turnkey program for Sleep Centers offering Out-of-Center Sleep Testing (OCST), will be featured at the SLEEP 2012 meeting in Boston, MA, June 9-13, at the NovaSom booth #120.
AccuSom Deliver provides a complete OCST logistics solution while the participating Sleep Center maintains complete clinical control of their patients. The new offering includes a cloud-based portal for Sleep Centers to enable efficient management of uncomplicated adult OSA diagnosis via OCST. The new portal is integrated with the AccuSom® testing device, the first and only wireless out-of-center sleep study device approved by the FDA. Leveraging NovaSom’s mHealth partnership with Verizon, data recorded by the device in the patient’s home is wirelessly transmitted to the Sleep Center portal for timely, efficient diagnosis.
Michael Coppola, MD, Chief Medical Officer and Vice President of Medical Affairs, NovaSom, said, “The simple truth is Sleep Centers alone don’t have the capacity to test the upwards of 40 million undiagnosed OSA sufferers across the country. OCST offers a highly convenient option with the potential to significantly improve patient access to testing. NovaSom’s Sleep Center program is unique in that it offers a clinically accurate solution that radically shortens time to diagnosis, while removing the capital expenditure and administrative burdens that often make out-of-center sleep testing impractical for centers to implement at scale.”
Leveraging more than ten years’ experience with turnkey OCST, the AccuSom Deliver program allows Sleep Centers to enjoy the scale and operating efficiency of the NovaSom’s proprietary MediTrack® operating platform and StudyViewer® interpretation portal. Once a sleep specialist prescribes an OCST through the cloud-based portal, NovaSom ships the device directly to the patient’s home. NovaSom’s Clinical Team provides proactive, 24/7 clinical support to patients throughout the testing protocol. Upon completion, test data is transmitted wirelessly via the Verizon Network to the portal and presented in a user-friendly display ready for sleep specialist interpretation.
Richard Hassett, MD, CEO, NovaSom, said, “As major healthcare payers increasingly require home sleep testing for uncomplicated OSA, it makes sense for Sleep Centers to incorporate an accurate, efficient out-of-center sleep testing model to ensure patients continue to be cared for by trained sleep specialists. Our AccuSom Deliver partnership program is designed to facilitate out-of-center sleep testing in a way that is flexible with the Sleep Center’s daily spike in demand. It offers Sleep Centers the ability to significantly extend their reach in the community with a highly convenient test to expand their market opportunity.”
Dr. Coppola, also President and Chief Medical Officer of the American Sleep Apnea Association and a practicing board-certified sleep specialist in Massachusetts, will be available to discuss AccuSom Deliver at the SLEEP 2012 Conference in NovaSom’s booth #120, from June 9-13, 2012.
NovaSom’s sleep testing technology directly measures the parameters recommended by the American Academy of Sleep Medicine to diagnose OSA, and has been proven clinically equivalent to traditional polysomnography in two peer-reviewed publications. For more information about NovaSom’s OCST technology and the AccuSom Deliver program, please visit www.NovaSom.com.
Obstructive Sleep Apnea (OSA) affects 40 million Americans, of which 18 million have moderate to severe disease. Of these, a startling 85% of sufferers are undiagnosed and therefore untreated, generating significant medical expense for patients and the healthcare system. Nearly half of all OSA patients also suffer from one or more serious health conditions such as diabetes, hypertension or heart failure that is either aggravated or caused by OSA. Treating OSA reduces medical expenses, improves patient quality of life and lowers associated health risks.
About NovaSom, Inc.
NovaSom, Inc. is the market leader in Obstructive Sleep Apnea (OSA) home testing, with the first FDA-cleared system, NovaSom® Home Sleep Test, and the second generation AccuSom® Home Sleep Test, the first and only FDA-cleared wireless HST. The NovaSom home sleep testing technology and MediTrack® portal have been shown to provide in-home, clinically equivalent diagnosis of OSA at a significantly reduced cost as compared to in-facility testing for uncomplicated, adult OSA. NovaSom’s home sleep tests are currently covered for more than 165 million U.S. lives, through partnerships with major health insurers.
NovaSom also offers comprehensive service programs that are utilized by payers, employers, primary care and sleep specialist physicians nationwide, that enable significant cost savings for OSA management. In an effort to combat the growing OSA epidemic, NovaSom also partners with sleep centers, enabling sleep specialists to offer clinically appropriate patients an alternative, convenient testing option, expanding access to diagnosis and treatment.
NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and is approved by CMS as an Independent Diagnostic Testing Facility. For more information, visit www.NovaSom.com.